Back to Trades
Boyle Scott N
Chief Business OfficerCIK 0001913897
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Boyle Scott N, Chief Business Officer, has filed 1 SEC report (2026), all concentrated in C4 Therapeutics, Inc. (CCCC), totaling $17.0K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Feb 18 | CCCC C4 Therapeutics, Inc. | Boyle Scott N | Chief Business Officer | Grant | $17.0K |
1 filing